Thomas J Dilling. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Antibodies, Monoclonal, Humanized/administration & dosageAntineoplastic Combined Chemotherapy Protocols/therapeutic useCarboplatin/administration & dosageCarcinoma, Non-Small-Cell Lung/drug therapyCarcinoma, Non-Small-Cell Lung/mortalityCarcinoma, Non-Small-Cell Lung/radiotherapyCetuximabClinical Trials, Phase I as TopicClinical Trials, Phase III as TopicDose Fractionation, RadiationHospitals, High-VolumeHumansIncidenceLung Neoplasms/drug therapyLung Neoplasms/mortalityLung Neoplasms/radiotherapyPaclitaxel/administration & dosageQuality of LifeRadiation Injuries/epidemiologyRadiotherapy DosageRetreatment/adverse effectsRetrospective StudiesTreatment Outcome
Substances： See more » Antibodies, Monoclonal, HumanizedCarboplatinPaclitaxelCetuximab
Year: 2014 PMID： 25539360 DOI： 10.1016/j.ijrobp.2014.08.333
Source DB: PubMed Journal: Int J Radiat Oncol Biol Phys ISSN： 0360-3016 Impact factor: 7.038